|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Displaying 121 - 140 of 414 stories.
September 12, 2008
Biopharmaceutical company Novacea (San Francisco) and privately held specialty pharma company Transcept Pharmaceuticals (Pt. Richmond, CA) say they have agreed to merge. The...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Transcept-to-Acquire-Novacea_14201.html September 8, 2008
Biocatalysis technology company Codexis (Redwood City, CA) says it has expanded its manufacturing collaboration with intermediates and active pharmaceutical ingredient (API) producer...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Codexis-Arch-Pharmalabs-Expand-Manufacturing-Collaboration_14050.html September 8, 2008
Boehringer Ingelheim says it has formed a production alliance with pharmaceutical company Hisoar (Taizhou, China), under which Hisoar will manufacture pharma intermediates and...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Chinese-Firm-to-Supply-APIs-to-Boehringer_14051.html September 8, 2008
Siegfried (Zofingen, Switzerland) posted a 33% increase in Ebit for the first half of this year, to SF28.5 million ($25.7million) on sales up 1%, to SF160 million. Earnings...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Siegfried-Posts-Higher-Earnings-and-Flat-Sales_14052.html September 8, 2008
Pronova Biopharma (Lysaker, Norway) says it has entered into an agreement with an undisclosed third-party manufacturer for the supply of pharmaceutical intermediates, which will enable...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Pronova-Signs-Intermediates-Deal_14053.html September 8, 2008
Sanofi-Aventis (Paris) says it has completed the acquisition of Symbion Consumer (Melbourne) for A$560 million ($479 million). Symbion Consumer manufactures, markets, and distributes...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-Buys-Australian-Firm_14054.html September 4, 2008
Sigma Aldrich Fine Chemicals (SAFC; St Louis, MO) today announced plans to invest almost $30 million to build manufacturing capacity for high-potency active pharmaceutical ingredients...http://www.chemweek.com/sections/pharma_and_fine_chemicals/SAFC-Injects-$30-Million-to-Build-Pharma-Ingredients-Capacity_13991.html September 3, 2008
BASF Plant Science and the Flanders Institute for Biotechnology (VIB; Ghent, Belgium) say today they have signed a “major cooperation agreement” in the field of plant...http://www.chemweek.com/sections/pharma_and_fine_chemicals/BASF-Signs-"Major"-Plant-Biotech-Research-Deal_13957.html August 25, 2008
DSM Biologics, a unit of DSM, says it has signed a biopharmaceutical manufacturing agreement with biotech firm MorphoSys (Martinsried, Germany). The deal calls for DSM to develop and...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-Biologics-to-Produce-Antibody-for-MorphoSys_13789.html August 25, 2008
Roche says it has signed an agreement to sell worldwide rights of four of its pharmaceutical products to specialty pharma company Meda (Solna, Sweden) for a total of €120 million...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Roche-Sells-Four-Products-to-Swedish-Firm_13790.html August 25, 2008
The U.S. Federal Trade Commission (FTC; Washington) has cleared the tender offer of Alkaloida Chemical Company Exclusive Group (Tiszavasvari, Hungary), a Sun Pharmaceutical Industries...http://www.chemweek.com/sections/pharma_and_fine_chemicals/FTC-Clears-Sun-Pharmas-Offer-to-Buy-Taro_13791.html August 25, 2008
Fresenius Kabi (Bad Homburg, Germany), a unit of health care group Fresenius SE, says it has completed the acquisition of Indian generics and active pharmaceutical ingredients (API)...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Fresenius-Kabi-Increases-Stake-in-Dabur-Pharma_13792.html August 18, 2008
WeylChem (Frankfurt), a custom manufacturer of chemical intermediates and active ingredients, says it plans to start manufacturing reagents on an industrial scale. The company will...http://www.chemweek.com/sections/pharma_and_fine_chemicals/WeylChem-to-Add-Industrial-Scale-Reagent-Manufacturing_13647.html August 18, 2008
Lonza says it has formed a business unit in Guangzhou, China, called Lonza Engineering, which will provide engineering, facility design, and maintenance services to local...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-Forms-Engineering-Unit-in-China_13648.html August 18, 2008
Otsuka Chemical Co. (Osaka) has agreed to acquire Ito Life Sciences, parent company of American Peptide (Sunnyvale, CA), from Itoham Foods (Nishinomiya, Japan), American Peptide says...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Otsuka-Chemical-to-Buy-American-Peptide_13649.html August 18, 2008
Cambrex (East Rutherford, NJ) posted second-quarter net profits down 19%, to $1.8 million, on sales up by 5%, to $66.2 million. Sales of generic active pharmaceutical ingredients...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambrex-Profits-Fall-on-Low-Generic-API-Sales_13650.html August 7, 2008
Monsanto disclosed today that it is looking for a buyer for its bovine milk boosting drug Posilac recombinant bovine somatotropin (rBST). Monsanto did not disclose if it was yet in...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Monsanto-Seeks-Buyer-for-Controversial-Milk-Boosting-Drug_13486.html August 4, 2008
Roche has announced plans to acquire two biotechnology firms in North America. The company says it has agreed to purchase biotech company Arius Research (Toronto) for about C$191...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Roche-to-Acquire-Two-Firms-in-North-America_13419.html August 4, 2008
Teva Pharmaceutical Industries Ltd. (Petach Tikva, Israel) says it has completed the acquisition of Bentley Pharmaceuticals (Exeter, NH) for about $360 million. Bentley produces...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Teva-Buys-U-S-Generic-Drugmaker_13420.html August 4, 2008
Saltigo (Langenfeld, Germany), a wholly owned subsidiary of Lanxess, says it will increase prices worldwide by a minimum of 15% for 1,2,4 triazole, effective immediately. The company...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Saltigo-Increases-Triazole-Prices_13421.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
